Impaired Release of Vitamin D in Dysfunctional Adipose Tissue: New Cues on Vitamin D Supplementation in Obesity

Context Vitamin D accumulates in adipose tissue (AT), and vitamin D deficiency is frequent in obesity. Objective We hypothesize that trafficking of vitamin D is altered in dysfunctional AT. Design, Patients, Settings Fifty-four normal-weight and 67 obese males were recruited in a prospective study and randomly assigned to supplementation with 50 µg/wk 25-hydroxyvitamin-D3 or 150 µg/wk vitamin D3 for 1 year, raising dosage by 50% if vitamin D sufficiency [serum 25-hydroxyvitamin-D3 >50 nmol/L], was not achieved at 6 months; 97 subjects completed the study. Methods Vitamin D3 and 25-hydroxyvitamin-D3 were quantified by HPLC-MS in control and insulin-resistant (IR) 3T3-L1 cells and subcutaneous AT (SAT) from lean and obese subjects, incubated with or without adrenaline; expression of 25-hydroxylase (Cyp27a1), 1α-hydroxylase (Cyp27b1), and vitamin D receptor (Vdr) was analyzed by real-time polymerase chain reaction. Results In IR adipocytes, uptake of D3 and 25-hydroxyvitamin-D3 was higher, but, after adrenaline stimulation, the decrement in D3 and 25-hydroxyvitamin-D3 was stronger in control cells, which also showed increased expression of Cyp27a1 and Cyp27b1 and higher levels of 25-hydroxyvitamin-D3. In SAT from obese subjects, adrenaline-induced release of D3 and 25-hydroxyvitamin-D3 was blunted; in both IR cells and obese SAT, protein expression of β2-adrenergic receptor was reduced. Supplementation with 25-hydroxyvitamin-D3 was more effective in achieving vitamin D sufficiency in obese, but not in normal weight subjects. Conclusion Dysfunctional AT shows a reduced catecholamine-induced release of D3 and 25-hydroxyvitamin-D3 and altered activity of vitamin D-metabolizing enzymes; for these reasons supplementation with 25-hydroxyvitamin-D3 is more effective in obese individuals.

[1]  S. Cremers,et al.  Vitamin D Storage in Adipose Tissue of Obese and Normal Weight Women , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  M. Abbas.  Physiological functions of Vitamin D in adipose tissue , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  P. Arner,et al.  Impaired atrial natriuretic peptide-mediated lipolysis in obesity , 2016, International Journal of Obesity.

[4]  A. Frigo,et al.  25-Hydroxycholecalciferol response to single oral cholecalciferol loading in the normal weight, overweight, and obese , 2016, Osteoporosis International.

[5]  V. M. Nisha,et al.  Insulin resistance by TNF-α is associated with mitochondrial dysfunction in 3T3-L1 adipocytes and is ameliorated by punicic acid, a PPARγ agonist , 2015, Molecular and Cellular Endocrinology.

[6]  Carlos Teles Santos,et al.  Obesity and vitamin D deficiency: a systematic review and meta‐analysis , 2015, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[7]  R. Jorde,et al.  Vitamin D3 increases in abdominal subcutaneous fat tissue after supplementation with vitamin D3. , 2015, European journal of endocrinology.

[8]  D. James,et al.  Selective Insulin Resistance in Adipocytes* , 2015, The Journal of Biological Chemistry.

[9]  E. Giovannucci,et al.  The Importance of Body Weight for the Dose Response Relationship of Oral Vitamin D Supplementation and Serum 25-Hydroxyvitamin D in Healthy Volunteers , 2014, PloS one.

[10]  E. Orwoll,et al.  Vitamin D and DBP: The free hormone hypothesis revisited , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[11]  R. Mason,et al.  Uptake of 25-hydroxyvitamin D by muscle and fat cells , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[12]  S. Chirumbolo,et al.  Phenotypic shift of adipocytes by cholecalciferol and 1α,25 dihydroxycholecalciferol in relation to inflammatory status and calcium content. , 2014, Endocrinology.

[13]  P. Arner,et al.  Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance , 2014, Trends in Endocrinology & Metabolism.

[14]  H. Bischoff-Ferrari,et al.  Pharmacokinetics of oral vitamin D(3) and calcifediol. , 2014, Bone.

[15]  H. Bischoff-Ferrari,et al.  Pharmacokinetics of oral vitamin D3 and calcifediol. , 2014, Bone.

[16]  L. Rejnmark,et al.  Expression of vitamin D-metabolizing enzymes in human adipose tissue—the effect of obesity and diet-induced weight loss , 2013, International Journal of Obesity.

[17]  S. Peltier,et al.  Vitamin D metabolism, functions and needs: from science to health claims , 2013, European Journal of Nutrition.

[18]  Dan Gao,et al.  Vitamin D signalling in adipose tissue , 2012, British Journal of Nutrition.

[19]  R. Heaney,et al.  Volumetric Dilution, Rather Than Sequestration Best Explains the Low Vitamin D Status of Obesity , 2012, Obesity.

[20]  M. Wabitsch,et al.  Protocol for effective differentiation of 3T3-L1 cells to adipocytes. , 2012, Analytical biochemistry.

[21]  M. Kiely,et al.  Relative effectiveness of oral 25-hydroxyvitamin D3 and vitamin D3 in raising wintertime serum 25-hydroxyvitamin D in older adults. , 2012, The American journal of clinical nutrition.

[22]  Chao Sun,et al.  p38 MAPK regulates calcium signal-mediated lipid accumulation through changing VDR expression in primary preadipocytes of mice , 2011, Molecular Biology Reports.

[23]  J. Glowacki,et al.  Effects of 25-Hydroxyvitamin D3 on Proliferation and Osteoblast Differentiation of Human Marrow Stromal Cells Require CYP27B1/1α-Hydroxylase , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  A. Kalueff,et al.  25-Hydroxyvitamin D3 is an agonistic vitamin D receptor ligand , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[25]  J. Eisman,et al.  Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index. , 2009, The American journal of medicine.

[26]  R. Heaney,et al.  Vitamin D3 Distribution and Status in the Body , 2009, Journal of the American College of Nutrition.

[27]  J. Tegnér,et al.  ApoB100-LDL Acts as a Metabolic Signal from Liver to Peripheral Fat Causing Inhibition of Lipolysis in Adipocytes , 2008, PloS one.

[28]  Yan Jiang,et al.  1α,25-Dihydroxyvitamin D hydroxylase in adipocytes , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[29]  M. Garaulet,et al.  Insulin effect on adipose tissue (AT) adiponectin expression is regulated by the insulin resistance status of the patients , 2008, Clinical endocrinology.

[30]  E. Blaak,et al.  Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity , 2008, Physiology & Behavior.

[31]  B. Dawson-Hughes,et al.  Body Size and Serum 25 Hydroxy Vitamin D Response to Oral Supplements in Healthy Older Adults , 2008, Journal of the American College of Nutrition.

[32]  J. Jakobsen,et al.  25-Hydroxyvitamin D3 affects vitamin D status similar to vitamin D3 in pigs – but the meat produced has a lower content of vitamin D , 2007, British Journal of Nutrition.

[33]  E. L. Arrese,et al.  Stimulation of lipolysis enhances the rate of cholesterol efflux to HDL in adipocytes , 2007, Molecular and Cellular Biochemistry.

[34]  E. Lander,et al.  Reactive oxygen species have a causal role in multiple forms of insulin resistance , 2006, Nature.

[35]  Roger Y. Tsien,et al.  Insulin disrupts β-adrenergic signalling to protein kinase A in adipocytes , 2005, Nature.

[36]  W. Grant,et al.  Benefits and requirements of vitamin D for optimal health: a review. , 2005, Alternative medicine review : a journal of clinical therapeutic.

[37]  Roger Y Tsien,et al.  Insulin disrupts beta-adrenergic signalling to protein kinase A in adipocytes. , 2005, Nature.

[38]  L. Hellström,et al.  Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives , 1996, Diabetologia.

[39]  S. Rössner,et al.  Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta2-adrenoceptors , 1994, Diabetologia.

[40]  P. Arner,et al.  Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots , 2004, Diabetologia.

[41]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[42]  M. Holick,et al.  Decreased bioavailability of vitamin D in obesity. , 2000, The American journal of clinical nutrition.

[43]  F. Muskiet,et al.  Rat adipose tissue rapidly accumulates and slowly releases an orally-administered high vitamin D dose , 1998, British Journal of Nutrition.

[44]  C. Pecqueur,et al.  In vivo resistance of lipolysis to epinephrine. A new feature of childhood onset obesity. , 1997, The Journal of clinical investigation.

[45]  W. Saris,et al.  beta-Adrenergic stimulation of skeletal muscle metabolism in relation to weight reduction in obese men. , 1994, The American journal of physiology.

[46]  M. Horowitz,et al.  Effects of skin thickness, age, body fat, and sunlight on serum 25-hydroxyvitamin D. , 1993, The American journal of clinical nutrition.

[47]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[48]  C. Rich,et al.  Deposition in and release of vitamin D3 from body fat: evidence for a storage site in the rat. , 1971, The Journal of clinical investigation.

[49]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.